Related Content
- NewslettersJuly 10, 2025
ERISA Litigation Update
- NewslettersJune 21, 2025 – July 3, 2025
SEC Staff Publishes Revisions to S-K Item 103 Legal Proceedings C&DIs
- AlertJune 23, 2025
DOL Abandons ESG Rule in Investment Duties Regulation; Rescinds Cryptocurrency Guidance
- NewslettersJune 7, 2025 – June 20, 2025
SEC Withdraws Proposed Amendments to Shareholder Proposal Rule
- NewslettersMay 26, 2025 – June 6, 2025
SEC Investor Advisory Committee Considers Shareholder Engagement and Non-GAAP Disclosures
- AlertApril 18, 2025
Supreme Court Decides Pleading Standard to Allege ERISA Prohibited-Transaction Claims, Favoring Plaintiffs
- NewslettersApril 11, 2025
ERISA Litigation Update
- NewslettersJanuary 17, 2025
ERISA Litigation Update
- Awards and RankingsJune 11, 2025
The Legal 500 US 2025 Recognizes 44 Goodwin Practices and 172 Lawyers
- Awards and RankingsJune 5, 2025
Chambers USA 2025 Recognizes a Record Number of Goodwin Practices and Lawyers for Exceptional Client Service
- Speaking EngagementsApril 25, 2025
The Supreme Court’s Decision in Cunningham v. Cornell University: Key Takeaways and Impacts
- Speaking EngagementsApril 17, 2025
Strafford Webinar: 2025 ERISA Litigation Update: DOL ESG Rule, Fiduciary Duty Claims, Legal Theories and Tactics
- Speaking EngagementsJanuary 23, 2025
Webinar: Cunningham v. Cornell University at the Supreme Court: An Oral Argument Readout
- Awards and RankingsNovember 7, 2024
Best Lawyers Best Law Firms 2025 Names Goodwin Biotechnology and Life Sciences Law Firm of the Year for the Eighth Time and Recognizes 55 Practice Areas
- Awards and RankingsJune 13, 2024
The Legal 500 US 2024 Recognizes 44 Goodwin Practices and 186 Lawyers
- Awards and RankingsJune 6, 2024
Chambers USA 2024 Recognizes Goodwin Practices and Lawyers for Exceptional Client Service